COMMUNIQUÉS West-GlobeNewswire

Curetis Launches Unyvero System and LRT Cartridge for Lower Respiratory Tract Infections in the U.S.
07/06/2018
Curetis Launches Unyvero System and LRT Cartridge for Lower Respiratory Tract Infections in the U.S. Multiple scientific conference contributions at ASM Microbe highlight benefits of Unyvero LRT First commercial [...]
Madrigal Pharmaceuticals Prices Public Offering of Common Stock
07/06/2018
CONSHOHOCKEN, Pa., June 06, 2018 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq:MDGL), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutic [...]
Optinose Announces Pricing of Public Offering of Common Stock
07/06/2018
YARDLEY, Pa., June 06, 2018 (GLOBE NEWSWIRE) -- OptiNose, Inc. (NASDAQ:OPTN), announced today the pricing of an underwritten public offering of 5,000,000 shares of its common stock at a public offering price of $22.25 [...]
MPX Appoints Robert Petch to the Board of Directors
07/06/2018
TORONTO, June 06, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“ MPX ” or the “ Company ”) (CSE:MPX) (OTC:MPXEF) is pleased to announce that Robert Petch has joined the board of directors of MPX. Mr. Petch has [...]
Arog Pharmaceuticals Announces Clinical Presentations on Crenolanib at the 23rd Congress of the European Hematology Association
07/06/2018
DALLAS, June 06, 2018 (GLOBE NEWSWIRE) -- Arog Pharmaceuticals, Inc., a privately held, clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs to treat unmet [...]
XORTX to Commence Trading on the OTCQB Venture Market
06/06/2018
CALGARY, Alberta, June 06, 2018 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (CSE:XRX) (OTCQB:XRTXF), a biopharmaceutical company focused on developing innovative therapies to treat [...]
Ascendis Pharma Announces Orphan Drug Designation Granted for TransCon PTH as Treatment for Hypoparathyroidism
06/06/2018
COPENHAGEN, Denmark, June 06, 2018 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs, today [...]
Advanced Proteome Therapeutics Announces Appointment of Bill Dickie as Chief Executive Officer, President and Director
06/06/2018
VANCOUVER, British Columbia, June 06, 2018 (GLOBE NEWSWIRE) -- Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSXV:APC) (FSE:0E8) is pleased to announce the appointment of Mr. Bill Dickie as Chief [...]
Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
06/06/2018
TUSTIN, Calif., June 06, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by [...]
Align Technology to Speak at Upcoming Financial Conferences
06/06/2018
SAN JOSE, Calif., June 06, 2018 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq:ALGN) today announced that the company is scheduled to speak at upcoming financial conferences. The presentation, as noted below, will [...]
Momenta Pharmaceuticals to Webcast Presentation at the Goldman Sachs 39th Annual Global Healthcare Conference
06/06/2018
CAMBRIDGE, Mass., June 06, 2018 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA), today announced that it will present at the Goldman Sachs 39th Annual Global Healthcare Conference. The presentation is [...]
Lundbeck reaches voluntary agreement in principle with U.S. Department of Justice
06/06/2018
Valby, Denmark, 6 June 2018 - H. Lundbeck A/S (Lundbeck) today announced that its U.S. subsidiary Lundbeck LLC has reached an agreement in principle to resolve the U.S. Department of Justice (DOJ) investigation related [...]
National Brain Tumor Society-Championed Childhood Cancer STAR Act Signed Into Law
06/06/2018
Boston, MA, June 06, 2018 (GLOBE NEWSWIRE) -- Today, the Childhood Cancer STAR (Survivorship, Treatment, Access and Research) Act was signed into law. This pivotal moment marks a major victory for brain tumor and [...]
GW Pharmaceuticals to Present at the Goldman Sachs 39th Annual Global Healthcare Conference
06/06/2018
LONDON and CARLSBAD, Calif., June 06, 2018 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (NASDAQ:GWPH) (GW, the Company or the Group), a biopharmaceutical company focused on discovering, developing and commercializing [...]
Nohla Receives EMA PRIME Designation for Dilanubicel (NLA101) to Treat Hematopoietic Stem Cell Transplant Patients
06/06/2018
First Product to Achieve PRIME Designation for Hematopoietic Stem Cell Transplant Patients SEATTLE, June 06, 2018 (GLOBE NEWSWIRE) -- Nohla Therapeutics, a leading developer of universal, off-the-shelf cell therapies [...]
Nova Scotia Exports Mental Health Resources
06/06/2018
HALIFAX, Nova Scotia, June 06, 2018 (GLOBE NEWSWIRE) -- Two evidence-based mental health resources originally developed in Nova Scotia, are launching in schools and universities across the United Kingdom today. [...]
Essilor: Disclosure of Share Capital and Voting Rights Outstanding as of May 31, 2018
06/06/2018
Disclosure of Share Capital and Voting Rights Outstanding as of May 31, 2018 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]
Essilor : Nombre total de droits de vote et d'actions composant le capital social au 31 mai 2018
06/06/2018
Nombre total de droits de vote et d'actions composant le capital social au 31 mai 2018 (Article L.233-8 II du Code de Commerce et les articles 221-1 et 223-16 du Règlement Général de l'AMF) Charenton-le-Pont, France (le [...]
VALNEVA : Déclaration d'actions et de droits de vote - MAI 2018
06/06/2018
VALNEVA Déclaration d'actions et de droits de vote - MAI 2018 Dénomination sociale : VALNEVA Adresse du siège social : World Trade Center Lyon - Tour Oxygène, 10-12 Boulevard Marius Vivier Merle, 69003 Lyon Marché [...]

Pages